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Vitamin A elicits a broad array of immune responses through its metabolite, retinoic acid (RA). Recent
evidence indicates that loss of RA leads to impaired immunity, whereas excess RA can potentially promote
inflammatory disorders. In this review, we discuss recent advances showcasing the crucial contributions of
RA to both immunological tolerance and the elicitation of adaptive immune responses. Further, we provide
a comprehensive overview of the cell types and factors that control the production of RA and discuss how
host perturbations may affect the ability of this metabolite to control tolerance and immunity or to instigate
pathology.Introduction
In the early 20th century, E.V. McCollum and Thomas Osborne
independently embarked on studies to identify dietary constitu-
ents that were essential for mammalian health and survival. By
using different dietary supplements, they arrived at the seminal
conclusion that a single factor present in lipids was essential
for growth and survival, which they coined ‘‘fat-soluble factor
A’’ (Wolf, 1996). Studies over the years have demonstrated the
pleiotropic influence of this nutrient, subsequently designated
vitamin A, ranging from eyesight and organogenesis to metabo-
lism and immunological fitness (Acin-Perez et al., 2010; Duester,
2008; Underwood, 2004; Ziouzenkova et al., 2007). Vitamin A’s
critical contribution to immunological health is shown by the
fact that its supplementation dramatically curbs young-child-
hood mortality in endemic regions of malnutrition (Rahmathullah
et al., 1990; Sommer, 2008; Sommer et al., 1986). The vitamin
A metabolite, retinoic acid (RA), first received attention as an
interventional therapy upon discovery that it could substitute
for more toxic chemotherapeutic regimens to dramatically
improve the prognosis of acute promyelocytic leukemia (APL),
a malignancy caused by genetic translocations with the retinoic
acid receptor (RAR), RARa (de The´ and Chen, 2010). Although
numerous investigations of APL have highlighted the ability of
RA to promote myeloid cell differentiation (Kastner et al.,
2001), over the last 20 years it has become clear that this metab-
olite influences multiple immune cell lineages and an array of
immunological functions (Cantorna et al., 1995; Chun et al.,
1992). In this review, we discuss recent advances that have es-
tablished RA as central to both immunological tolerance and the
elicitation of adaptive immune responses. Further, we provide
a comprehensive overview of the cell types and factors that
control the production of RA and discuss how host perturbations
may affect the ability of this metabolite to control tolerance and
immunity or to instigate pathology.
Acquisition, Storage, and Metabolism of Vitamin A
Vitamin A is a fat-soluble essential nutrient obtained through
foods containing vitamin A precursors (i.e., carotenoids) or
vitamin A itself in the form of retinyl esters (Figure 1; Harrison,
2005; Yeum and Russell, 2002). Subsequent to absorption andarrival into circulation, retinyl esters enter the liver, where most
of the vitamin A in the body is stored (Blomhoff and Blomhoff,
2006). Liver retinyl esters are continually hydrolyzed into retinol
and deployed into circulation (Wolf, 2007). Bile, which drains
from the liver into the small intestinal duodenum, is also enriched
in retinol (Jaensson-Gyllenback et al., 2011). Once inside a cell,
widely expressed alcohol dehydrogenases (ADH) oxidize retinol
into retinal, which can then bind to more selectively expressed
retinal dehydrogenases (RALDH) for oxidation into retinoic
acid (RA). RA can be generated in multiple isoforms; however,
the all-trans isoform predominates in most tissues (Mic et al.,
2003) and, therefore, the immunological effects of this com-
pound will be the focus in this review. Although RA is constitu-
tively present in serum at low amounts (Kane et al., 2008),
RALDH induction is a tightly controlled process and subject to
change during perturbations to homeostasis (Figure 2).
Retinoic Acid Sythesis and Induction of Cellular
Migration into Mucosal Sites
Prior to its function, RA binds to nuclear receptors, including
retinoic acid receptors (RAR), retinoid X receptors (RXR), and,
under certain circumstances, PPARbd (Chambon, 1996; Schug
et al., 2007). Notably, all-trans RA exclusively binds RXR via
heterodimers with the RAR family, which consists of three
receptors: RAR alpha (RARa), beta (RARb), and gamma (RARg)
(Chambon, 1996).
Appropriate immune responses depend on the ability of
effector and regulatory lymphocytes to home to the site of infec-
tion or injury. In this regard, dendritic cells (DCs) have been
shown to foster lymphocyte migration into tissues where antigen
was initially encountered (Campbell and Butcher, 2002). For
instance, DCs from gastrointestinal tract and associated
lymphoid tissue (GALT), but not the periphery, were shown to
induce the mucosal homing markers—integrin heterodimer
a4b7 and chemokine receptor CCR9—on stimulated effector
T cells (Johansson-Lindbom et al., 2003, 2005; Mora et al.,
2003). The insight that mucosal DCs triggered a4b7 and CCR9
expression through the capacity to synthesize RA was based
on the seminal observation that adding RA to T cells during acti-
vation selectively induced these gut homing markers (IwataImmunity 35, July 22, 2011 ª2011 Elsevier Inc. 13
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Figure 1. Vitamin A Metabolism and Major
Cellular Sources of Retinoic Acid during
Homeostasis
Dietary vitamin A is absorbed in the intestine and
transported through the lymphatics into blood
circulation where it enters the liver for storage.
Retinol chaperoned by retinol binding protein
(RBP) is constitutively deployed from the liver into
circulation. It is also secreted in bile that drains into
the small intestine. Upon entry into cells, retinol is
reversibly oxidized into retinal via the alcohol
dehydrogenase (ADH) family. Depending on the
cell type (see table), retinal can undergo irrevers-
ible metabolism into retinoic acid (RA) via retinal
dehydrogenases (RALDH). The table provides an
overview of major cellular sources of RA during
steady-state conditions. Table includes cellular
location, the isoform(s) of RALDH that are ex-
pressed, and the factors known to induce RALDH
expression in each cell type.
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signaling and transcription in cultures containing GALT DCs
reversed induction of a4b7 and CCR9 (Iwata et al., 2004; Svens-
son et al., 2008). Recently, RA was revealed to predominantly
affect the a4 subunit of a4b7 via binding of RARa to a RAR
response element within the regulatory region of the gene that
encodes a4 (DeNucci et al., 2010; Kang et al., 2011). A retinoic
acid response element half-site was also recently discovered
in the promoter region of CCR9, which permits RARa-RXR het-
erodimer binding (Ohoka et al., 2011). These data coupled with
the prominent baseline expression of Rara, the gene encoding
RARa, in CD4+ T cells, pinpoint RARa as an important mediator
of lymphocyte trafficking. Nevertheless, they do not exclude
a role for other RARs inmediating the regulation of thesemarkers
on other defined subsets.
An assessment of vitamin A-synthesizing enzymes demon-
strated that GALT DCs express mRNA for Aldh1a2, the gene
encoding RALDH2 (Iwata et al., 2004; Schulz et al., 2009; Yokota
et al., 2009). Subsequent studies have shown that basal Aldh1a2
expression in GALT DCs is enriched in CD103+ DC subsets,
which induce a4b7 and especially CCR9 far more potently than
the CD103 DC compartment (Figure 1; Coombes et al., 2007;
Johansson-Lindbom et al., 2005; Yokota et al., 2009). In the
small intestinal LP, this population is uniquely equipped with
migratory capacity and therefore accumulates in the mesenteric
lymph nodes (MLN) (Bogunovic et al., 2009; Jaensson et al.,
2008; Jang et al., 2006; Schulz et al., 2009). CD103+ DCs within
the MLN and Peyer’s patches (PP) are comprised of two subsets
based on expression of integrin CD11b. The CD103+CD11b
subset is related to the CD103+CD11b and CD8a+ DC subsets
outside of the GALT (Edelson et al., 2010; Ginhoux et al., 2009;
Hildner et al., 2008). However, CD103+CD11 DCs residing at
other sites fail to produce appreciable RALDH, suggesting that
factors within the GI tract induce RA-synthesizing capacity in
this subset (Guilliams et al., 2010). In this regard, vitamin A itself14 Immunity 35, July 22, 2011 ª2011 Elsevier Inc.is indispensible for DC production of
Aldh1a2 during homeostasis (Jaensson-
Gyllenback et al., 2011; Molenaar et al.,
2011; Yokota et al., 2009). This may
involve Wnt-b-catenin-driven signals,because ablation of b-catenin in CD11c cells attenuates their
expression of RALDH (Manicassamy et al., 2010). Microbial
stimuli also appear to have an additional influence on RALDH
expression; moderate decreases were observed in GALT DCs
isolated from mice reared in germ-free conditions or genetically
deficient in the microbial signaling adaptor MyD88 (Guilliams
et al., 2010). Toll-like receptor 2 (TLR2)-stimulating ligands, in
particular, were found to most potently induce RALDH expres-
sion (Manicassamy et al., 2009; Wang and Sampson, 2011).
In addition to DCs, several nonhematopoietic lineages within
the gastrointestinal tract and associated lymphoid tissues
(GALT), such as epithelia (expressing Aldh1a1, encoding
RALDH1) and stromal cells (Aldh1a1, Aldh1a2, and Aldh1a3),
share the capacity to synthesize RA (Figure 1; Edele et al.,
2008; Hammerschmidt et al., 2008; Iliev et al., 2009; Iwata
et al., 2004; Molenaar et al., 2011). Intestinal epithelial cells
have been shown to imprint bone marrow DCs with signature
characteristics of LP DCs, via provision of soluble factors,
including RA (Edele et al., 2008; Iliev et al., 2009). They may
also provide RA in trans and reinforce the expression of mucosal
homing markers on lymphocytes. Stromal cells within the MLN
were also found to support mucosal homing, probably through
indirect effects on APCs (Figure 2; Hammerschmidt et al.,
2008; Stock et al., 2011). Altogether, these findings support
the observation of a prominent reduction in the number of
activated T lymphocytes within the intestinal effector sites in
adult mice reared on a vitamin A-deficient diet, as well as in
Rara-deficient (Rara/) mice (Hall et al., 2011; Iwata et al., 2004).
Other DC populations, particularly in the draining lymph nodes
of the skin and lung, express Aldh1a2 (Figure 1; Guilliams et al.,
2010). The finding that RA signaling occurs in sites not typically
associated with mucosal homing raises several interesting
points of discussion. First, crosstalk with other cells in these
tissues may modulate the capacity of DCs to induce mucosal
homing. For example, prostaglandin E2, from the stroma of
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Figure 2. The Role of Retinoic Acid in the Regulation of CD4+ T Cell
Homeostasis and Immunity in the GI Tract
TheGALT is a retinoic acid (RA)-rich environment, containing a vast presence of
RA-synthesizing cells, including resident epithelia (IECs) and stromal cells
(SCs), as well as migratory CD103+ DCs. RA produced by IECs may confer
characteristic features to lamina propria DCs, whereas RA produced by SCs in
the draining mesenteric lymph nodes may reinforce lymphocyte acquisition of
mucosal homing markers and potentially other effector functions. During
steady-state conditions (top), RA sustains oral tolerance and helps maintain
barrier integrity. These processes are mediated in large part by the ability of
RA to support the induction of Foxp3+ iTreg and Th17 cells. Lamina propria
CD103+ DCs induce and recruit heterogeneous CD4+ T cell populations during
steady state, as result of their ability to respond to commensalmicrobial signals
andproduce bothRAand TGF-b. During inflammation or infection (bottom), the
inflammatory milieu triggers altered cytokine production by CD103+ DCs,
leading to RARa-dependent effector CD4+ T cell activation and differentiation.
Innate cell populations, including antigen-presenting cells, are recruited during
inflammation and also contribute toRAproduction. Factors in the inflammatory
milieu, including TLR-ligands and the cytokine GM-CSF, promote RALDH
activity in CD103+ DCs and potentially in recruited innate cells.
Immunity
Reviewperipheral tissues, was recently shown to antagonize RALDH
expression (Stock et al., 2011). Second, RA signaling may also
influence migration to peripheral sites. In this regard, integrin
a4 can also form heterodimers with integrin subunit, b1, which
is rapidly upregulated in response to T cell receptor (TCR) stim-
ulation and impedes formation of the a4b7 heterodimer (DeNucciet al., 2010). a4b1 binds to VCAM-1, which is present on endothe-
lial cells and upreguated during inflammation, so RA may addi-
tionally influence migration to peripheral sites during inflamma-
tion (Figure 3; Henninger et al., 1997; Muller, 2011). Further
studies are essential to understand how crosstalk between
DCs and other cells can modulate RALDH activity, which may
produce a better understanding of how accessory cells
contribute to the regulation of immunity during both homeostasis
and inflammation. Collectively these findings indicate that RA
signaling occurs in tissues throughout the host and suggest
that apart from mucosal homing, it plays a general role in both
tolerance and inflammation.
Retinoic Acid in Plasma Cell Differentiation
and Mucosal IgA
The discovery that RA was critical for the generation of immuno-
globulin A (IgA)-secreting B cells offered further evidence of
a multifactorial role for RA in mucosal immunity (Mora et al.,
2006). A number of studies have demonstrated the potent
capacity of DCs from the intestinal LP, MLN, and PP to drive
naive B cell differentiation into IgA+ B cells (Macpherson and
Uhr, 2004;Mora et al., 2006; Uematsu et al., 2008), and the ability
of stromal-derived cells to support IgA+ class switching in acti-
vated B cells (Fagarasan et al., 2001; Suzuki et al., 2010).
Synthesis of RA by GALT DCs is crucial for the generation of
IgA+ B cells, as shown by the fact that antagonism of RA
signaling markedly reduce IgA+ production (Mora et al., 2006;
Uematsu et al., 2008). Complementing this finding, addition of
RA to DC cocultures in which DCs lacked the capacity to synthe-
size RA restores IgA+ production. Notably, microbial-induced
cytokines, such as IL-6, are also integral cofactors in this
process (Mora et al., 2006; Uematsu et al., 2008). In addition,
although inhibitory at high concentrations (Mora et al., 2006),
TGF-b-mediated signals also play a decisive role in IgA+ produc-
tion (Cazac and Roes, 2000). This has been verified in systems
analyzing the capacity of mucosal stromal cells to foster IgA+
B cell generation (Fagarasan et al., 2001; Suzuki et al., 2010).
In a manner analogous to peripheral DCs, peripheral follicular
dendritic cells are able to efficiently support IgA+ production
only when treated with RA and a MyD88-dependent microbial
stimulus (Suzuki et al., 2010). This gain of function is dependent
on the ability of RA signaling to induce secretion of TGF-b in
peripheral follicular dendritic cells. RA signaling promotes
a similar effect (i.e., induction of TGF-b production) in bone
marrow-derived DCs via inhibition of suppressor of cytokine
signaling 3 (SOCS3) activity (Feng et al., 2010). These findings
suggest interdependency between TGF-b- and RA-propagated
signals in several cell lineages.
Another significant source of IgA+ production is B1-B cells,
which contribute to mucosal integrity during homeostasis and
early responses to pathogens. RAwas recently shown to enforce
the homeostatic maintenance of this compartment through
direct regulation of the transcription factor NFATc1 (Maruya
et al., 2011). Combined with the capacity of RA to generate
IgA+ B cells and facilitate their mucosal localization, vitamin A
deficiency leads to a severe decrease in intestinal IgA and
a marked decrease in the serum (Maruya et al., 2011; Mora
et al., 2006). Altogether, these findings underscore the impor-
tance of RA in IgA responses and humoral immunity.Immunity 35, July 22, 2011 ª2011 Elsevier Inc. 15
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Figure 3. RA Synergizes with an Inflammatory Milieu to Promote
Pathology
During inflammation, increasing RA signaling can potentiate the production of
inflammatory cytokines by DCs, and in turn promote effector T cell differenti-
ation. Direct interactions of RA with T cells may further contribute to the
activation status of the cells and promote localization to inflamed tissues. RA
may also engender the formation of tertiary lymphoid structures and facilitate
chronic inflammation.
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ReviewRetinoic Acid in Extrathymic Treg Cell Induction
and Oral Tolerance
Foxp3 regulatory T (Treg) cells maintain both peripheral and
mucosal homeostasis throughout the lifespan of the host (Jose-
fowicz and Rudensky, 2009; Kim et al., 2007). Treg cells typically
develop during thymic selection processes; however, they also
develop extrathymically in response to chronic antigen stimula-
tion or exposure to environmental and food antigen at mucosal
sites (Curotto de Lafaille and Lafaille, 2009). Development of
inducible Treg (iTreg) cells, but not thymic-derived Treg cells,
requires transcription factor binding to the intronic enhancer
element (enhancer-1) of the foxp3 locus, also known as
conserved noncoding sequence 1 (CNS1). iTreg cell develop-
ment is also dependent on several soluble mediators, including
TGF-b, IL-2, and, as recent data demonstrate, RA (Hall et al.,
2011; Knoechel et al., 2005; Kretschmer et al., 2005; Mucida
et al., 2005; Tone et al., 2008; Zheng et al., 2010).
The insight that RA served as a cofactor in the generation of
iTreg cells stemmed from in vitro findings that relative to splenic
DCs, MLN and LP DCs potently induced iTreg cell differentiation
in the presence of TGF-b (Coombes et al., 2007; Mucida et al.,
2007; Sun et al., 2007). Separation of MLN DCs and LP DCs
based on CD103 expression revealed that the CD103+ subsets
were specifically able to yield iTreg cells in the absence of exog-
enous factors, implying that RA signaling potentially contributed
to this process (Coombes et al., 2007; Sun et al., 2007). Indeed,
a pan-RAR antagonist strongly inhibited iTreg cell generation
(Coombes et al., 2007; Mucida et al., 2007; Sun et al., 2007).
Blockade of TGF-b in cocultures with CD103+ GALT DCs also
diminished iTreg cell generation. The coordinate ability of GALT
DCs to produce both RA and TGF-b may involve conditioning
signals from RA during developmental maturation (Figure 2;
Feng et al., 2010). Assessment of DCs in a retinoic acid response
reporter mouse revealed abundant RAR binding activity in GALT16 Immunity 35, July 22, 2011 ª2011 Elsevier Inc.CD103+ DCs (Jaensson-Gyllenback et al., 2011). The level of
RAR binding activity in DCs from several tissues correlated
with both the concentration of retinol and the percentage of
CD103+ DCs expressing RALDH2 in those tissues, which
suggests that DC conditioning by RA may occur in situ. Further-
more, GALT CD103+ DCs highly expressed mRNA for the gene
encoding RARa, implicating this receptor as a dominant medi-
ator of such conditioning signals (Jaensson-Gyllenback et al.,
2011).
The addition of RA to cocultures with splenic DCs and TGF-b
also dramatically enhanced iTreg cell induction (Benson et al.,
2007; Mucida et al., 2007, 2009; Sun et al., 2007). This effect is
dependent on T cell expression of RARa (Hill et al., 2008), which
is upregulated upon stimulation in the presence of TGF-b
(Schambach et al., 2007). Remarkably, exogenous RA can
sustain iTreg cell generation in conditions that typically oppose
it, such as the presence of certain inflammatory cytokines (IL-6,
IL-21) and high costimulatory environments (Benson et al.,
2007; Mucida et al., 2007; Xiao et al., 2008). Stimulation of
CD4+ T cells in the presence of TGF-b induces IL-6R expression,
which is reversedwith the additionofRA (Figure 2;Hill et al., 2008;
Xiao et al., 2008). Because RA did not appear to enhance the
inherently unstable phenotype of iTreg cells (Floess et al., 2007;
Hill et al., 2008), RA-mediated repression of IL-6R could poten-
tially explain why iTreg cells generated in the presence of RA
were reportedly more stable in vivo after adoptive transfer (Ben-
son et al., 2007). Corroborating in vitro findings, the generation of
iTreg cells in response to antigen feeding is abrogated in animals
deficient in vitamin A and, therefore, lacking RA (Hall et al., 2011).
Oral tolerance—the active suppression of inflammatory
responses to food and other orally ingested antigens—is
critically dependent on the generation of iTreg cells (Curotto de
Lafaille et al., 2008; Weiner et al., 2011). Recent evidence indi-
cates that in addition to supporting iTreg cell differentiation,
RA-mediated trafficking of T cells is required for a sustained
expansion of iTreg cell numbers in the gut (Hadis et al., 2011).
This expansion in numbers is propagated through IL-10-medi-
ated interactions with resident CD103 antigen-presenting cells
(APCs). In previous studies, similar interactions were shown to
contribute to both the induction and maintenance of Treg cells
(Denning et al., 2007; Murai et al., 2009). Altogether, these find-
ings indicate that RA signaling is a keystone in the development
of oral tolerance.
In the absence of RA, other mechanisms may compensate for
the loss of these tolerogenic processes. For instance, elevated
frequencies of Foxp3IL-10+ Tr1 cells have been reported in
vitamin A-deficient mice and could be generated in vitro in the
presence of RAR antagonists andmicrobial-inducedDCproduc-
tion of IL-6 and IL-21 (Maynard et al., 2009). Despite the impor-
tance of RA for generation of iTreg cells, neither the frequency
nor absolute numbers of Treg cells are reduced during vitamin
A deficiency (Hall et al., 2011). Thymic Treg cell differentiation
is also intact in Rara/ animals (Hill et al., 2008). Although these
findings suggest that there are distinct requirements for induc-
ible versus thymic-derived Treg cells, it still remains unclear
whether intrathymic Treg cell differentiation and regulatory func-
tion is impacted in the absence of RA.
In vivo requirements notwithstanding, RA is insufficient to
induce Foxp3 in the absence of TGF-b (Benson et al., 2007;
Immunity
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responsiveness to TGF-b is a prerequisite for RA to access
Foxp3 differentiation programs. In this regard, blockade of
TGF-bRI kinase activity, which inhibits TGF-b-induced Smad2
and Smad3 phosphorylation (Sorrentino et al., 2008), diminished
TGF-b-mediated iTreg cell generation and abrogated the addi-
tive effect of RA (Xu et al., 2010). Several preceding studies
noted that RA enhances the total expression of Smad3 in acti-
vated CD4+ T cells; however, TGF-b is required to trigger
Smad3 activation (i.e., phosphorylation) (Nolting et al., 2009;
Xiao et al., 2008). Furthermore, TGF-b was observed to prevent
the intracellular degradation of RA (Takeuchi et al., 2011),
prompting the possibility that RA and TGF-b cooperatively
promote enhanced Smad3 activity. Based on the importance
of Smad3 activation in CNS1-mediated Foxp3 expression
(Tone et al., 2008), the role of RA in the regulation of CNS-1
was examined, which led to the identification of a potential
RAR binding site (Xu et al., 2010). Accordingly, RA was shown
to dramatically enhance TGF-b-induced chromatin accessibility
and Smad3 binding in CNS1. The strong association between
RA and the regulation of CNS1 not only provides a tentative
molecular mechanism for the enhancement of iTreg cell genera-
tion, but further suggests that RA synthesis pathways may be
manipulated during infection and inflammation to shift the
balance between Treg and effector T cells and in turn influence
immunopathology.
Influence of Retinoic Acid on Effector CD4+ T Cell
Differentiation and Function
The role of RA in TGF-b-dependent responses has been further
evaluated in Th17 cell differentiation. Th17 cells, which produce
IL-17A (IL-17), IL-17F, IL-21, and IL-22, promote control of
bacteria and fungal infections at mucosal sites (Littman and
Rudensky, 2010). They are induced in response to TGF-b,
combinations of the Stat3 signaling cytokines—IL-6, IL-21, and
IL-23—and IL-1 (Korn et al., 2009). Although linked to the
pathogenesis of autoimmune responses (Iwakura et al., 2011),
Th17 cells provide an important layer of protection at mucosal
interfaces and are typically detected during steady state in these
regions (Ivanov et al., 2006, 2008). Several recent studies
revealed that Th17 cells are virtually ablated in the GALT of
mice reared on a vitamin A-deficient diet during steady state
(Cha et al., 2010; Wang et al., 2010). In concert with the loss of
Th17 cells, the ability of APCs to produce IL-6, which promotes
Th17 cell polarization, is reduced in vitamin A-deficient mice (Hall
et al., 2011). Despite the likelihood that additional factors are
complicit in the diminished number of Th17 cells during vitamin
A deficiency, these data suggest that RA is critical for the
in vivo differentiation and/or survival of Th17 cells. In support
of this, in conjunction with microbial stimulation, a low dose of
RA (1 nM) in splenic DC cocultures was found to potentiate
Th17 cell generation (Uematsu et al., 2008). These findings
suggest that a synergy between RA- and microbial-driven
signals promote Th17 cell differentiation in vivo (Figure 2).
Importantly, the ability of RA to support Th17 cell differentiation
probably results from combined actions on DCs and T cells,
because addition of RA to Th17 cell-polarizing conditions in
APC-less cultures did not enhance Th17 cell differentiation
(Wang et al., 2010).In parallel with the initial discovery that RA enhanced iTreg cell
differentiation, RA was observed to suppress Th17 cell genera-
tion (Elias et al., 2008; Kang et al., 2007; Mucida et al., 2007).
RA was shown to inhibit IL-6R and IL-23R upregulation induced
by TGF-b and IL-6, respectively (Xiao et al., 2008; Zhou et al.,
2007). Accordingly, RA supplementation in vitamin A-replete
settings could suppress Th17 cell responses and IL-23-driven
immunopathology during Listeria monocytogenes infection and
autoimmune experimental encephalitis (Mucida et al., 2007;
Xiao et al., 2008). Thus, RA is required for the in vivo promotion
of Th17 cell differentiation, and it also may directly contribute
to Th17 cell regulation.
In addition to Th17 cells, RA can exert direct regulatory effects
on other effector T cell populations (Hill et al., 2008). For
instance, RA was shown to inhibit IFN-g production from CD8+
T cells and Th1 cells (Cantorna et al., 1995, 1996; Stephensen
et al., 2002). A previous study argued that such regulation might
have contributed to impaired Th2 cell responses to the parasitic
infection Trichinella spiralis during vitamin A deficiency (Carman
et al., 1992). RAwas also shown to relieve the inhibitory influence
of effector T cells in the generation iTreg cells by directly sup-
pressing their production of IL-4 and IL-21, which was previously
demonstrated to potently antagonize iTreg cell generation (Hill
et al., 2008; Korn et al., 2007; Nurieva et al., 2007; Wei et al.,
2007). Further investigation into the temporal regulation of reti-
noid receptor expression during helper T cell polarization should
clarify the molecular mechanisms by which RA controls cytokine
production in various effector T cell subsets. Although the
direct effects of RA on effector T cells should continue to be
explored in more pathological contexts, these findings support
a model in which RA-rich microenvironments can limit cytokine
production by terminally differentiated effector T cells and,
thus, T cell-mediated tissue pathology.
Retinoic Acid-Retinoic Acid Receptor Signaling
in CD4+ T Cell Activation
The recent descriptions of RA in immunoregulation have in some
ways overshadowed the importance of this metabolite in gener-
ating functional immunity. Indeed, several studies have noted
potent adjuvant effects of RA during infection (Dawson et al.,
2009; Yamada et al., 2007). One aspect in the amplification of
these responses may involve the vital role of RA in T cell activa-
tion. For instance, in serum-free cultures, RA dramatically
enhances TCR-mediated CD4+ T cell proliferation in an IL-2-
dependent manner (Engedal et al., 2006). The NFAT family of
transcription factors regulates an array of functions in multiple
cell types; in T cells these include production of IL-2 and the
full acquisition of effector properties (Macian, 2005; Peng
et al., 2001). mRNA expression of multiple NFAT isoforms, which
is reduced in B1-B cells during vitamin A deficiency, rebounds to
normal amounts after treatment with RA. NFAT proteins are also
markedly reduced in T cells during vitamin A deficiency and it is
possible that RA regulates NFAT transcription and/or stability in
these cells, as well (Maruya et al., 2011). Interestingly, NFATc2
was recently shown to cooperate with RARa-RXR heterodimers
to induce CCR9, whereas NFATc1 inhibited CCR9 induction
(Ohoka et al., 2011). These findings suggest that RA establishes
an intimate link between T cell activation, effector function, and
homing properties. It will be important to determine whetherImmunity 35, July 22, 2011 ª2011 Elsevier Inc. 17
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tially regulated in distinct anatomical sites and how their modu-
lation converges with RA availability in these sites to influence
expression of homing markers.
Naive CD4+ T cells basally express the genes encoding RARa
(Rara) and RARg (Rarg) (Hall et al., 2011; Ohoka et al., 2011).
Although previous data suggest that RARg is dispensable for
CD4+ T cell activation (Dzhagalov et al., 2007), recent data reveal
that RARa is important for this process (Hall et al., 2011). Specif-
ically, Ca2+ mobilization in response to TCR-CD3 engagement is
impaired in CD4+ T cells from Rara/ mice or normal cells
exposed to a pan-RAR antagonist (Hall et al., 2011). Ca2+ mobi-
lization results in NFAT translocation into the nucleus, so these
data suggest that both early and sustained T cell activation are
impaired when RA signaling is deficient (Feske, 2007). In this
regard, activation of the mTOR kinase pathways, which play
important roles in directing helper T cell responses, are also
reduced in Rara/ T cells (Delgoffe et al., 2009, 2011; Zhang
et al., 2011). The reductions in these signaling pathways may, in
part, contribute to the immunodeficient state observed in animals
devoid of RA-RARa signaling, which will be discussed below.
Precisely how RA-RARa signals mediate early T cell activation
events is unclear. RARa is potent transcriptional regulator of gene
networks and known to constitutively bind to DNA. Such binding
may exert a tonic influence on the DNA binding capacity of other
proteins involved in the regulation of T cell activation. For
instance, RA-RARa regulates DNA binding of the AP-1 transcrip-
tion factor, c-Jun, which is involved in responses to stress- and
TCR-mediated signals (Schu¨le et al., 1991). In addition to its
well-appreciated nuclear activity, extranuclear functions of
RARa have also been described (Rochette-Egly and Germain,
2009). In this regard, RARawas observed to regulate expression
of the phosphatase MKP-1, which is an important mediator of
effector T cell differentiation (Lee et al., 1999; Zhang et al., 2009).
Furthermore, RARamayassociatewith amembrane and/or cyto-
solic signaling scaffold important in T cell activation (Rochette-
Egly and Germain, 2009). Recent findings indicate that RXR
expression is barely detectable in naive T cells, suggesting that
the effects of RARa on T cell activation may proceed indepen-
dently of RXR heterodimerization. Conversely, RAR-RXR hetero-
dimerization is required for the acquisition of mucosal homing
markers (Ohoka et al., 2011). Although further research into the
mechanism by which RA-RARa regulates T cell signaling is
needed, one can construct a model in which RA regulates adap-
tive T cell responses through dichotomous roles: on the one hand
promoting the initiation of effector T cell differentiation and, on the
other hand, restraining inflammatory T cell responses in tissues.
Retinoic Acid in Infection and Immunity
Recent human data highlight the correlation between vitamin A
status and T cell function (Ahmad et al., 2009). Although vitamin
A has gained widespread acceptance as a clinical health inter-
vention, skepticism of its efficacy has lingered because of
inconsistency in outcomes of various vitamin A supplementa-
tion programs and a subpar understanding of the mechanisms
it employs to combat infectious disease (Sommer, 2008; Win-
tergerst et al., 2007). The latter, in and of itself, poses a signifi-
cant challenge to developing efficacious supplementation
programs. Studies utilizing various animal models of vitamin A18 Immunity 35, July 22, 2011 ª2011 Elsevier Inc.or retinoid receptor deficiency have begun to close this knowl-
edge gap, revealing an integral role for RA in vitamin A-depen-
dent immunity. Impaired and/or dysregulated T cell responses
have been observed in various models of infection and vacci-
nation strategies during vitamin A and/or retinoid receptor
deficiency (Carman et al., 1992; Dzhagalov et al., 2007; Hall
et al., 2011; Stephensen et al., 2004). During infection with
Toxoplasma gondii, an intracellular replicating pathogen
controlled by IFN-g (Suzuki et al., 1988), the acute Th1 cell
response and parasite clearance are substantially impaired in
vitamin A-deficient mice (Hall et al., 2011). Similarly, vaccination
with an E. coli-derived heat-labile enterotoxin mucosal adju-
vant, LT(R129G), which simultaneously elicits Th1 and Th17
cells (Hall et al., 2008), yields diminished Th1 and Th17 cell
responses in these animals. Short-term treatment with RA
immediately prior to and during challenge completely rescued
CD4+ T cell responses both to acute T. gondii infection and
vaccination in vitamin A-deficient mice (Hall et al., 2011). These
findings demonstrated an essential role for RA in the develop-
ment of Th1 and Th17 cell responses.
RA signaling appears to control the fate of T cell immunity
largely through RARa and RARg. The CD4+ T cell response to
vaccination with LT(R129G) was strongly diminished in Rara/
mice (Hall et al., 2011). CD4+ T cell activation was reduced in the
absence of RARa, but additional functional impairments may
have also factored into this outcome. Preliminary evidence
suggests that RARa regulates not just the proper maturation
of DCs in the GALT (Jaensson-Gyllenback et al., 2011) but
also their ability to drive inflammatory responses in certain path-
ologic settings, which will be discussed below (Depaolo et al.,
2011). Future studies employing lineage-targeting strategies
will be integral for discerning the contributions of RARa in
individual cell types to immunological outcomes. Although the
role of RARa in CD8+ T cell function remains to be explored,
RARg, which is dispensable for CD4+ T cell and humoral
responses, was shown to be required for full effector differenti-
ation of CD8+ T cells in response to infection with Listeria
monocytogenes (Dzhagalov et al., 2007).
A direct role for RARg in CD8+ T cell activation has not yet been
addressed; however, this receptor controls optimal macrophage
production of inflammatory cytokines in response to microbial
stimuli (Dzhagalov et al., 2007). A role for RA signaling in macro-
phages is consistent with another study, which showed that
RA enhanced macrophage activation in response to in vitro
infection with Mycobacterium tuberculosis (Yamada et al.,
2007). Altogether, these data illustrate the ability of RA to regu-
late a network of innate and adaptive immune cell functions,
which through nonredundant receptor signaling pathways power
functional immune responses. More research is required to
elucidate how RARb signals fit into the control of vitamin
A-dependent immunity. In contrast to the other RARs, RARb
expression appears to largely depend on RA itself and, therefore,
may play a prominent role in the regulation of mucosal immune
responses (Molenaar et al., 2011; Suzuki et al., 2010). RARb
was also found to regulate the recruitment of lymphoid tissue-
inducer cells during embryogenesis via stromal cell induction
of CXCL13 (van de Pavert et al., 2009). Thus, it will be worthwhile
to examine the role of RA in the formation of tertiary lymphoid
structures during chronic inflammation.
Immunity
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Chronic inflammatory syndromes arise as a consequence of
genetic polymorphisms in concert with accumulating environ-
mental exposure to toxins, pathogens, and diet (Yazdanbakhsh
et al., 2002). Western diets are becoming increasingly associ-
ated with a higher prevalence of inflammatory disorders,
including allergies and inflammatory bowel diseases (Garrett
et al., 2010; Wang and Sampson, 2011). Several studies have
suggested that in vivo iTreg cell generation can prevent and/or
mitigate these manifestations (Curotto de Lafaille and Lafaille,
2009; Lacy-Hulbert et al., 2007; Travis et al., 2007). In this regard,
treatments that promote RA metabolism may constitute an
effective strategy to restore the regulatory balance during
chronic inflammation. For example, treatment with the TLR2
agonist zymosan was shown to induce RALDH production by
nonmucosal DCs and ameliorated pathology in a model of
autoimmunity (Figure 2; Manicassamy et al., 2009). Neverthe-
less, in previous studies, mice fed a diet high in vitamin A
exhibited more vigorous responses against grafts and tumors,
suggesting that elevated retinoid levels were potentially detri-
mental in certain inflammatory contexts (Figure 3; Malkovsky´
et al., 1983a, 1983b). In this regard, a recent study demonstrated
that RA-driven signals in an inflammatory environment fostered
reactivity to dietary glutens in a mouse model of celiac disease
(Figure 3; Depaolo et al., 2011; Jabri and Sollid, 2009). In partic-
ular, RA was demonstrated to synergize with an IL-15-rich milieu
and potentiate production of IL-12 and IL-23 by mucosal DCs,
diminishing their capacity to promote iTreg cells and leading to
exacerbated responses to Gliadin (Depaolo et al., 2011). These
data reflect several reports describing a possible association
between pharmacological retinoid treatment and spontaneous
development of inflammatory bowel disease and point to
elevated activity of vitamin A metabolic pathways as potential
instigators of chronic inflammation (Figure 3; Crockett et al.,
2010; Reddy et al., 2006).
Concluding Remarks
Recent insights into the role of RA in the promotion and regu-
lation of multiple immunological pathways draw new attention
to the sweeping influence of vitamin A in immunity. Though
long on the radar of health experts trying to combat immuno-
deficiencies in developing nations, vitamin A is often over-
looked in developed regions where access to this nutrient is
plentiful. New data reveal that multiple factors influence the
generation of RA, including vitamin A itself, fatty acids, TLR
ligands, and GM-CSF, which promote RA synthesis and pros-
taglandin E2, which inhibits RA synthesis (Manicassamy et al.,
2009; Stock et al., 2011; Szatmari et al., 2006; Yokota et al.,
2009). Greater understanding of how these factors play into
RA synthesis during homeostasis and inflammation will be
essential for assessing their efficacy as therapeutic modalities
in the treatment of syndromes in which retinoid imbalances
may be involved. In summary, the potential of RA to transform
from an essential to pathological mediator of immune
responses raises many questions on how vitamin A metabolism
affects disease. Furthermore, because retinoids are prevalent
in clinical settings (de Lera et al., 2007), an additional consider-
ation in their use may be the patient’s risk factors for inflamma-
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